Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03935425 · ClinicalTrials.gov registry record · NA
FitMi Plus Home Therapy for Stroke Patients
A NA study, sponsored by Flint Rehabilitation Devices.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT03935425: Completed NA study, sponsored by Flint Rehabilitation Devices.
NCT03935425 is a NA study that has completed, run by Flint Rehabilitation Devices. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03935425, a NA study, has completed, sponsored by Flint Rehabilitation Devices.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
The investigators will investigate the efficacy of a newly developed functional exercise device (FitMi Plus) for people in the chronic stage after a stroke compared to the FitMi Basic (i.e. without functional exercises). FitMi Plus combines objects commonly used during activities of daily living with sensors that can track and record the patient's direction and degree of movement as they perform specific functional tasks described on a computer.
Primary Outcome
A self-reported measure of the quality of movement and amount of use of the impaired upper extremity across a set of activities of daily living. Minimum value = 0, maximum value = 5, higher scores = better outcome
Interventions
- DEVICE FitMi Plus
- DEVICE FitMi Basic
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2021-11-29 |
| Est. Completion | 2022-12-31 |
| Phase | NA |
What the finished NCT03935425 record still lists
NCT03935425 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which FitMi Plus is the first listed.
NCT03935425 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03935425 about?
NCT03935425 is a clinical study titled "FitMi Plus Home Therapy for Stroke Patients". The investigators will investigate the efficacy of a newly developed functional exercise device (FitMi Plus) for people in the chronic stage after a stroke compared to the FitMi Basic (i.e. without functional exercises). FitMi Plus combines objects commonly used during activities of daily living wit...
What is the current status of trial NCT03935425?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2021-11-29. Estimated completion is 2022-12-31.
What interventions are being tested in trial NCT03935425?
The interventions under investigation include: FitMi Plus (DEVICE), FitMi Basic (DEVICE).
Who is sponsoring clinical trial NCT03935425?
This trial is sponsored by Flint Rehabilitation Devices, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03935425's enrollment target sits among peer trials
50 1279th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI